about
Pharmacotherapy of autonomic failureConfounders of vasovagal syncope: orthostatic hypotension.Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure?Clinical Relevance of Orthostatic Hypotension in Neurodegenerative Disease.Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension.Vascular endothelial function and blood pressure regulation in afferent autonomic failureAssociation of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson diseaseAngiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failureOrthostatic hypotension: managing a difficult problem.Management approaches to hypertension in autonomic failure.Cardiovascular complications in patients with autonomic failure.Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.The Pharmacology of Autonomic Failure: From Hypotension to Hypertension.Congenital eyelid ptosis, decreased glomerular filtration, and orthostatic hypotension: Answers.Association of blood pressure in the supine position with target organ damage in subjects over 60 years oldAdjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.Orthostatic hypotension and cardiovascular risk.Acute cyclooxygenase inhibition and baroreflex sensitivity in lean and obese adults.Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.Treatment of supine hypertension in autonomic failure: a case series.Pure Autonomic Failure.Cerebral microbleeds and blood pressure abnormalities in Parkinson's disease.Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurol
P2860
Q28240235-F9234E45-C73D-44F5-B3A1-97F5A2DD5B37Q33162128-42981722-7490-4E7D-94EA-6622DAA4C2FAQ33164089-A8348C80-4246-4839-9F31-E4F814AF711CQ33166368-C40E7D8D-0B2A-4FC6-974B-165C7B948A5FQ34506047-D5FA1828-2268-46A2-84E7-EF094BC61F89Q35171817-D47E1406-9EE7-4F1F-A3FB-7BC79AB6D4B1Q36252230-322D5798-1060-4A7C-A496-2F5CC3ED3E1DQ36612182-DE7E79EB-F9EA-4F5A-9C18-98C1D7A92E65Q36943826-E3E626E3-56F0-417C-B0DC-4471D95CDE63Q38026735-D4378022-7D1A-4DE0-877C-FBD5F9C955A9Q38384306-F3F84A10-37B2-4CB9-8F4A-AE16A60E7F89Q38658416-6E2C74AC-0A7C-4046-A14D-6F5D22504447Q39052115-91C8A93D-2D39-4E02-9672-7C5061DB105EQ41824560-8F9C5F89-B4DA-4A96-B54C-7402385E72D9Q42277389-F1301A37-36DA-424F-A225-CAAC457A5D92Q42324086-BE929E97-D793-4C39-842C-F6F4FDD20B9BQ42567616-0D1093B8-7259-4D0F-80A1-1FB10524E010Q47948834-3F802328-8C79-4A80-B7A5-CA9FD890DC1FQ48117806-02C731FC-7323-4B0F-A2A8-BC6C91D325E1Q50101682-8128794E-938B-48C1-937E-BCFEF43D26A6Q51685133-5B911B03-6228-4B4F-9BE8-479E1CC0C938Q55024081-2BEF557D-864B-477A-9941-4678D10B4BB6Q56382514-3D22FDC3-204B-46E4-AAD7-E7FBEC2A3A49
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Renal impairment of pure autonomic failure.
@en
Renal impairment of pure autonomic failure.
@nl
type
label
Renal impairment of pure autonomic failure.
@en
Renal impairment of pure autonomic failure.
@nl
prefLabel
Renal impairment of pure autonomic failure.
@en
Renal impairment of pure autonomic failure.
@nl
P2093
P2860
P1433
P1476
Renal impairment of pure autonomic failure.
@en
P2093
Alfredo Gamboa
Bonnie K Black
David Robertson
Emily M Garland
Italo Biaggioni
Luis Okamoto
Satish R Raj
Thomas L Davis
P2860
P304
P356
10.1161/HYPERTENSIONAHA.109.136853
P407
P577
2009-09-08T00:00:00Z